GlassScriptPhysician profile
Joseph C Bognet
NPI 1699752162
$38,719.16
in general payments reported to CMS, 2019-2025
79 companies · $4,597 in 2025
The $4,597 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,552 · 2020: $4,987 · 2021: $5,946 · 2022: $5,117 · 2023: $5,594 · 2024: $5,926 · 2025: $4,597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Education: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,694.40 |
| Education | $422.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $5,967.33 | 2019-2025 | Breztri, Farxiga, Lokelma |
| Abbvie INC. | $2,922.06 | 2019-2025 | Ubrelvy, Vraylar, Qulipta |
| Novo Nordisk INC | $2,760.98 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,627.07 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $2,330.35 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Mannkind Corporation | $1,254.04 | 2020-2025 | Afrezza |
| Amarin Pharma, INC. | $1,135.72 | 2019-2023 | |
| Amgen INC. | $1,119.02 | 2019-2025 | Repatha, Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,043.70 | 2019-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $1,038.98 | 2019-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $1,012.43 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $991.71 | 2021-2025 | Nuzyra, Xhance |
| Biocryst US Sales Co., LLC | $935.91 | 2021-2025 | Orladeyo |
| Esperion Therapeutics, INC. | $846.55 | 2020-2025 | Nexletol |
| Sunovion Pharmaceuticals INC. | $786.07 | 2019-2022 |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $759.40 | 2019-2023 | Uzedy |
| Allergan, INC. | $705.05 | 2019-2020 | |
| Astellas Pharma US INC | $622.63 | 2021-2025 | Veozah, Myrbetriq |
| Takeda Pharmaceuticals U.S.A., INC. | $597.11 | 2019-2025 | Takhzyro |
| Csl Behring | $596.83 | 2019-2025 | Haegarda, Andembry |
| Merck Sharp & Dohme LLC | $575.76 | 2019-2024 | Verquvo, Steglatro |
| Kowa Pharmaceuticals America, INC. | $454.10 | 2019-2024 | Seglentis, Livalo |
| Phathom Pharmaceuticals, INC. | $435.02 | 2024-2025 | Voquezna |
| Antares Pharma, INC. | $434.18 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Xeris Pharmaceuticals, INC. | $419.23 | 2022-2025 | Gvoke Hypopen |
| Pfizer INC. | $384.57 | 2019-2025 | |
| Abbott Laboratories | $379.04 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Horizon Therapeutics Plc | $358.39 | 2020-2022 | |
| Radius Health, INC. | $343.91 | 2022-2025 | Tymlos |
| Axsome Therapeutics, INC. | $291.12 | 2022-2025 | Auvelity |
| Shire North American Group INC | $269.80 | 2019 | |
| Exact Sciences Corporation | $233.90 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $226.79 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $224.59 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $222.49 | 2019-2023 | |
| Biohaven Pharmaceuticals, INC. | $194.73 | 2021 | |
| Idorsia Pharmaceuticals US INC | $194.38 | 2022-2023 | Quviviq |
| Pulmonx Corporation | $174.57 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Glaxosmithkline, LLC. | $167.25 | 2019-2025 | Shingrix, Arexvy |
| Biohaven Pharmaceutical Holding Company LTD. | $155.14 | 2022 | |
| Melinta Therapeutics, LLC | $152.67 | 2019 | |
| Organogenesis INC. | $149.55 | 2021 | |
| Lundbeck LLC | $140.94 | 2024 | Rexulti |
| Kyowa Kirin, INC. | $128.99 | 2024-2025 | Crysvita |
| Almatica Pharma LLC | $128.08 | 2021-2025 | Loreev Xr |
| Urovant Sciences INC | $124.74 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $124.74 | 2022 | |
| Sumitomo Pharma America, INC. | $114.28 | 2023-2025 | Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $113.69 | 2019-2025 | Eliquis |
| Opko Pharmaceuticals, LLC | $79.39 | 2019-2025 | Rayaldee |
| Cumberland Pharmaceuticals, INC. | $79.20 | 2020-2022 | |
| Ardelyx, INC. | $77.08 | 2024-2025 | Ibsrela |
| Seqirus USA INC | $73.65 | 2023-2025 | Fluad, Flucelvax, Fluad Quadrivalent |
| Alfasigma USA, INC. | $73.60 | 2020-2022 | |
| Pharming Healthcare, INC. | $71.68 | 2019 | |
| Mylan Specialty L.P. | $66.80 | 2024 | Yupelri |
| Tolmar, INC. | $66.14 | 2023-2024 | |
| Vbi Vaccine (Delaware) INC. | $65.67 | 2022-2023 | Prehevbrio |
| Madrigal Pharmaceuticals | $62.12 | 2025 | Rezdiffra |
| Biogen, INC. | $58.71 | 2024-2025 | Leqembi |
| Phadia US INC. | $56.14 | 2023-2025 | Immunocap |
| Avion Pharmaceuticals | $55.55 | 2019-2022 | |
| Halozyme INC | $53.44 | 2023 | |
| Amag Pharmaceuticals, INC. | $46.04 | 2020 | |
| Aimmune Therapeutics, INC. | $44.48 | 2025 | Zenpep |
| Azurity Pharmaceuticals, INC. | $34.68 | 2023-2024 | Edarbyclor, Edarbi |
| Philips North America LLC | $33.07 | 2022-2023 | |
| Gilead Sciences, INC. | $31.50 | 2019 | |
| Eisai INC. | $30.92 | 2020-2021 | |
| Ascensia Diabetes Care US INC. | $25.41 | 2024 | |
| Mission Pharmacal Company | $22.43 | 2019 | |
| Genentech USA, INC. | $21.25 | 2020 | |
| Nevro Corp. | $19.46 | 2019 | |
| Viatris Specialty LLC | $18.68 | 2025 | Yupelri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.85 | 2022 | |
| Therapeuticsmd, INC. | $17.80 | 2019 | |
| Amphastar Pharmaceuticals, INC. | $16.57 | 2024 | |
| Jazz Pharmaceuticals INC. | $16.22 | 2020 | |
| Vistapharm, INC. | $14.05 | 2021 |
Drugs and devices associated with these payments
Jardiance $1,070Breztri $854Farxiga $814Nuzyra $721Afrezza $716Ubrelvy $694Rybelsus $665Ozempic $665Vraylar $663Kerendia $653Mounjaro $607Orladeyo $598Qulipta $549Lokelma $543Wegovy $535Xyosted $450Voquezna $435Veozah $394Tymlos $326Verquvo $316Airsupra $303Xifaxan $274Auvelity $272Gvoke Hypopen $257Seglentis $247Repatha $244Cologuard Collection Kit $234Zepbound $228Livalo $221Otezla $208Haegarda $203Zephyr Delivery Catheter $175Pulmonx Chartis Tablet Console $175Chartis Catheter $175Zephyr Endobronchial Valve $175Freestyle Libre 3 $172Synthroid $153Takhzyro $149Rexulti $141Xarelto $135Tlando $130Crysvita $129Xhance $123Fasenra $118Gemtesa $114Uzedy $113Yupelri $85.48Ibsrela $77.08Nocdurna $76.18Quviviq $69.64Jatenzo $66.14Rezdiffra $62.12Vascepa $61.87Leqembi $58.71Freestyle Libre 2 $57.03Immunocap $56.14Flucelvax $54.57Fluad $54.57Nexletol $54.37Eliquis $50.62Zenpep $44.48Arexvy $39.99Shingrix $39.99Loreev Xr $34.21Steglatro $31.76Emgality $30.53Myrbetriq $29.83Andembry $28.57Entresto $28.49Abrysvo $28.31Prevnar 20 $28.31Eversense E3 Sensor Kit - Retail $25.41Prehevbrio $22.15Nurtec Odt $21.08(8874) Incourage $20.89Edarbyclor $19.68Fluad Quadrivalent $19.08Flucelvax Quadrivalent $19.08Rayaldee $18.15Edarbi $15.00Leqvio $13.83
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Bognet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.